Corporate insider profile
Nicholas A.J. Botwood Insider Trades
Nicholas A.J. Botwood has reported no open-market purchases on SEC Form 4 and is a net seller of $1,183,640 across 1 company. The most recent open-market transaction was reported on Jun 12, 2026. Source: SEC Form 4 filings.
Latest reported as Head of R&D, CMO of Syndax Pharmaceuticals Inc (SNDX).
SEC-reported filing activity is provided for research purposes and is not investment advice.
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$1,183,639.85
- Latest transaction
- Jun 12, 2026
Affiliated corporations
Reported company relationships
Transaction history
Open-market Transactions
Common questions
Nicholas A.J. Botwood insider trading FAQ
- Is Nicholas A.J. Botwood buying or selling stock?
- Across all SEC Form 4 open-market filings on record, Nicholas A.J. Botwood is a net seller of $1,183,640, with no open-market purchases reported. The latest transaction was reported on Jun 12, 2026.
- Which companies does Nicholas A.J. Botwood report insider trades for?
- Nicholas A.J. Botwood has reported open-market trades in Syndax Pharmaceuticals Inc (SNDX). The latest SEC-reported relationship is Head of R&D, CMO of Syndax Pharmaceuticals Inc (SNDX).
- Where does Nicholas A.J. Botwood's insider trading data come from?
- Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under reporting owner CIK 2066784, and refreshes this page daily.
